跳至主要内容
临床试验/TCTR20190822001
TCTR20190822001招募中未知

Evaluation of left atrial(LA) function using left atrial fractional area change (LAFAC) as a diagnostic tool for cardiac amyloidosis

Faculty of Medicine, Chiang Mai University0 个研究点目标入组 80 人开始时间: 2019年8月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. Patients diagnosed cardiac amyloidosis confirmed diagnostic criteria and tissue or bone marrow biopsy showing amyloid deposit.
  • 2. Echocardiography findings concomitant with cardiac amyloidosis and diagnosed by at least two experienced cardiologists.
  • 3. Hypertensive heart disease patients with LVH(LVMI>115g/m2in male or > 95 g/m2 in female with RWT > 0.42) and age matched to patients in cardiac amyloidosis group.
  • 4. HCM patients with LVH(LVMI>115g/m2 in male or>95g/m2in female with RWT > 0.42)
  • 5. Constrictive pericarditis patients with echocardiographic finding concomitant with Mayo Clinic echocardiographic criteria and diagnosed by at least two experienced cardiologists.
  • 6. Healthy subjects without heart disease with age matched with patients in cardiac amyloidosis group

排除标准

  • 1. Inadequate quality or unavailable echocardiographic study
  • 2 . Patients with atrial fibrillation

研究者

发起方
Faculty of Medicine, Chiang Mai University

相似试验

Evaluation of left atrial(LA) function using left... | 临床试验